Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating tirzepatide versus placebo in adults with Type 1 diabetes and obesity/overweight; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes, Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING